JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> BioPharma Services >> Media >> Pharma Newsletters >> Eurofins BioPharma Services Newsletter 27 - October 2020 >> New WebLab System offers real-time formulation analysis services

Eurofins’ new WebLab System offers real-time formulation analysis services

Sidebar Image

Junko Imoto, Research Fellow, Eurofins BioPharma Product Testing Kyoto, JunkoImoto@eurofins.com

There are a variety of dosage forms in pharmaceuticals, and formulation development is conducted daily so that the active ingredients work effectively and also patients can take them easily. In formulation development, it is very important not only to make sure that the pharmaceuticals are manufactured as designed; it is also important to analyse the structure of the drug product in order to investigate the cause when an abnormality occurs in the product after the market launch.

Eurofins BioPharma Product Testing Kyoto (BPT Kyoto) uses various imaging technologies to help visualise and analyse the structure of drug products. In formulation analysis, especially imaging analysis, it is critical to decide which part of the formulation should be focused on, which differs depending on each customer.

Eurofins BPT Kyoto has started its WebLab service in 2020. With this service, an analysis screen can be connected with the customer’s PC using the internet. A customer can witness the analytical work in real-time, without visiting the Eurofins Lab in Japan, by simply turning on the PC switch at the given analytical time. It is also possible to connect with multiple sites. Therefore, customers can efficiently and accurately perform their desired measurements by directly instructing analysts what they want them to pay more attention to, pointing out the positions where they want to analyse, and by having discussions with analysts, all in real-time manner. The WebLab system is now utilised as one of the best tools of working remotely in this COVID-19 situation.

Eurofins BPT Kyoto joined the Eurofins Group via Astellas Pharma in 2018 and has extensive experience in the field of formulation analysis. By utilising the WebLab system, it is possible to meet customer demands more reliably and in a timely manner.

For more information, visit: www.eurofins.co.jp/eurofins-biopharma-product-testing-kyoto/analytical-testing-services/advanced-expert-analysis/